We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Risk Factors Identified for Little-Known Lung Infections

By LabMedica International staff writers
Posted on 25 Mar 2014
Severe and sometimes fatal lung disease caused by a group of bacteria in the same family as those that cause tuberculosis is much more common than previously thought.

Nontuberculous mycobacteria (NTM) include more than 150 types of bacteria found in water and soil that can infect the lungs when inhaled, but unlike tuberculosis, NTM is not contagious and cannot spread from person to person.

Scientists at the University of Illinois (Chicago, IL, USA) analyzed mortality related to nontuberculous mycobacterial infections from 1999 through 2010 by examining multiple-cause-of-death data from the National Center for Health Statistics (Atlanta, GA, USA). More...
They analyzed age-adjusted mortality rates, trends, associations with demographic variables, and comorbid conditions and correlated this information with similar data for tuberculosis-related mortality during the same time.

The investigators found that NTM was listed as immediate cause of death for 2,990 people, of whom 87% were 55 or older, 85% were white, and 52% were female. NTM-related deaths also correlated with smoking, cancer, human immunodeficiency virus (HIV) infection, and chronic obstructive pulmonary disease. They also found that the age-adjusted NTM mortality rates were uneven across the USA. Tuberculosis-related deaths among ethnic groups were also disproportional as among those with tuberculosis, 4,847 (59%) were white.

The team suggested that both warm and dry climates may contribute to NTM disease and influence on mortality by different environmental factors, such as temperature, soil and water conditions. NTM demonstrated a strong relationship with some comorbid conditions such as chronic obstructive pulmonary disease, chronic respiratory failure, bronchiectasis, HIV, interstitial lung diseases, rheumatoid arthritis, hematopoietic malignancies and tobacco use. The infection is treatable, but antibiotic therapy is expensive and can take up to two years. Examples of nontuberculous mycobacteria that should be distinguished from tubercle bacilli are Mycobacterium chelonae, M. abscessus, M. fortuitum, and M. cosmeticum

Mehdi Mirsaeidi, MD, MPH, the lead author said, “People and physicians need to be aware of NTM, especially as we see more of it, and because it can look like a lot of other pulmonary diseases. Patients usually present with a cough, and correct diagnosis can take years. Having a better understanding of the risk factors associated with NTM will give us a better chance of diagnosing it faster. This is important, because it's largely a curable infection.” The study was published on March 14, 2014, in the journal Public Library of Science ONE.

Related Links:

University of Illinois
National Center for Health Statistics



New
Gold Member
Hematology Analyzer
Medonic M32B
Collection and Transport System
PurSafe Plus®
New
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The nanotechnology-based liquid biopsy test could identify cancer at its early stages (Photo courtesy of 123RF)

2-Hour Cancer Blood Test to Transform Tumor Detection

Glioblastoma and other aggressive cancers remain difficult to control largely because tumors can recur after treatment. Current diagnostic methods, such as invasive biopsies or expensive liquid biopsies,... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.